Questcor Pharmaceuticals Earnings Preview: Can This Streak Continue?

Questcor Pharmaceuticals (NASDAQ:QCOR) will report earnings after markets close on Tuesday, April 30th. Questcor Pharmaceuticals, Inc. develops and commercializes novel central nervous system-focused therapeutics that address significant unmet medical needs. The Company’s primary product is a natural source adrenocorticotropic hormone indicated for the treatment of acute exacerbations of multiple sclerosis, as well as a number of other conditions.

Here is your Cheat Sheet to Questcor Pharmaceuticals Earnings:

Earnings Expectations: Analysts expect earnings of $0.96 per share on revenues of $157.16 million. Currently, the company’s P/E ratio stands at 9.24.

Analyst Trends:

Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.97 to a profit $1.05. For the current year, the average estimate is a profit of $4.19, which is better than the estimate ninety days ago.

Earnings Trends:

Here’s how Questcor Pharmaceuticals has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 95.25 88.32 115.13 218.17 509.29
Diluted EPS ($) 0.49 0.40 0.54 1.21 3.14

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 75.54 95.97 112.45 140.34 160.53
Diluted EPS ($) 0.4724 0.58 0.65 0.91 1.025

Past Performance:
Questcor Pharmaceuticals has beat analyst estimates 4 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]